Bg pattern

DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Diclofenac-Lepori 1 mg/ml Eye Drops, Solution in Single-Dose Container

Diclofenac Sodium

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What Diclofenac-Lepori Eye Drops, Single-Dose Container is and what it is used for
  2. What you need to know before starting to use Diclofenac-Lepori Eye Drops, Single-Dose Container
  3. How to use Diclofenac-Lepori Eye Drops, Single-Dose Container
  4. Possible side effects
  5. Storage of Diclofenac-Lepori Eye Drops, Single-Dose Container
  6. Package Contents and Additional Information

1. What Diclofenac-Lepori Eye Drops, Single-Dose Container is and what it is used for

This medication belongs to the group of topical ophthalmic medications. It contains diclofenac sodium as the active ingredient, which is a non-steroidal anti-inflammatory drug (NSAID).

Diclofenac-Lepori Eye Drops, Single-Dose Container is used for:

  • Postoperative treatment of inflammation of the anterior segment of the eye.
  • Treatment of inhibition of miosis (pupil constriction) before and after cataract surgery.
  • Symptomatic treatment of chronic non-infectious conjunctivitis.
  • Treatment of ocular inflammation, eye pain, and photophobia after refractive surgery (performed to correct myopia, astigmatism, and hypermetropia).
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Diclofenac-Lepori Eye Drops, Single-Dose Container

Do not use Diclofenac-Lepori Eye Drops, Single-Dose Container

  • if you are allergic to the active ingredient or any of the other components of this medication (listed in section 6).
  • if you have asthma attacks, hives, or acute rhinitis when given acetylsalicylic acid or other medications with similar activity, inhibiting prostaglandin synthetase.
  • if you know you are sensitive to acetylsalicylic acid or to phenylacetic acid derivatives, which belong to the same chemical group as the active ingredient of this medication, or to other non-steroidal anti-inflammatory drugs (NSAIDs), as there is a possibility of cross-sensitivity to these medications.

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Diclofenac-Lepori Eye Drops, Single-Dose Container

  • In case of infection or when there is a risk of infection, your doctor may prescribe Diclofenac-Lepori Eye Drops, Single-Dose Container in combination with other appropriate treatment (e.g., antibiotics). Non-steroidal anti-inflammatory drugs (NSAIDs) may mask an acute infectious process.
  • If you have any problems stopping bleeding or are taking any medication that may prolong bleeding, inform your doctor before using Diclofenac-Lepori Eye Drops, Single-Dose Container (see section "Other medications and Diclofenac-Lepori Eye Drops, Single-Dose Container").
  • If you are using non-steroidal anti-inflammatory medications, such as diclofenac, or corticosteroids in the form of eye drops, consult your doctor before using this medication.

Do not exceed the recommended dose in the dosage instructions, as more frequent application than recommended may cause complications in the cornea.

Children

Diclofenac-Lepori Eye Drops, Single-Dose Container is not indicated for use in children, as experience with its use in them is limited.

Using Diclofenac-Lepori Eye Drops, Single-Dose Container with other medications

Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medication.

If you are taking non-steroidal anti-inflammatory medications, such as diclofenac, or corticosteroids, consult your doctor before using this medication, as there may be a risk of complications.

Before using other ophthalmic medications, wait at least 5 minutes between applications.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Diclofenac-Lepori Eye Drops, Single-Dose Container should not be used if you are in the last 3 months of pregnancy. You should not use Diclofenac-Lepori Eye Drops, Single-Dose Container during the first 6 months of pregnancy, unless it is strictly necessary and your doctor recommends it. If you need treatment during this period, you should take the minimum dose possible for the shortest time possible.

Oral formulations (e.g., tablets) of Diclofenac-Lepori Eye Drops, Single-Dose Container may cause adverse reactions in the fetus. It is unknown whether this same risk applies to Diclofenac-Lepori Eye Drops, Single-Dose Container when used for the eyes.

Although no adverse effects have been described as a result of its application, its use is not recommended during breastfeeding, unless the expected benefits outweigh the potential risks.

Driving and Using Machines

After instillation of Diclofenac-Lepori Eye Drops, Solution, you may experience temporary blurred vision. If this occurs, do not drive or use machines until this effect has disappeared.

Diclofenac-Lepori Eye Drops, Single-Dose Container contains boron

Do not administer to children under 12 years of age, as this medication contains boron and may affect fertility in the future.

3. How to use Diclofenac-Lepori Eye Drops, Single-Dose Container

Follow your doctor's instructions for administering this medication exactly. If you are unsure, consult your doctor or pharmacist again.

Your doctor will indicate the duration of your treatment with Diclofenac-Lepori 1 mg/ml Eye Drops, Single-Dose Container. Do not stop treatment before the indicated time.

The correct dose for the following cases is as follows:

  • Before surgery: 1 drop of the eye drops 3 to 5 times during the 3 hours before the operation, applied at regular time intervals, which means a maximum of 5 drops.
  • After surgery: 3 drops of the eye drops applied at regular time intervals, starting immediately after the operation. Then, during the required time period, 1 to 2 drops of the eye drops 3 to 5 times a day, which means a maximum daily dose of 10 drops.
  • Other indications: 1 to 2 drops of the eye drops 3 to 4 times a day, depending on the severity of the case, which means a maximum daily dose of 8 drops.

If you think the effect of Diclofenac-Lepori Eye Drops, Single-Dose Container is too strong or too weak, inform your doctor or pharmacist.

Use in Elderly Patients

There is no indication that the dose needs to be modified in elderly patients.

Use in Children

The use of Diclofenac-Lepori Eye Drops, Solution, Single-Dose Container is not indicated in children.

Instructions for the correct use of Diclofenac-Lepori Eye Drops, Single-Dose Container

  1. Separate a single-dose container by performing a downward movement, pulling it.

(Illustration)

  1. Gently tap the base of the single-dose container with the tip of your finger so that the eye drops flow towards the opening.

(Illustration)

  1. Gently turn the cap to open the container.

(Illustration)

  1. Apply the eye drops to the eye by pressing the base of the container repeatedly to facilitate the flow of the liquid, which may be hindered by air bubbles.

(Illustration)

If you use more Diclofenac-Lepori Eye Drops, Single-Dose Container than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone: 91 562 04 20.

If you forget to use Diclofenac-Lepori Eye Drops, Single-Dose Container

Do not apply a double dose to make up for forgotten doses. If you forget a dose, apply it as soon as you can, except if it is almost time for the next dose; then return to your regular administration schedule. If you forget several doses, consult your doctor.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Talk to your doctor or pharmacist if you experience any of the following side effects:

Very Common

Ocular disorders: eye pain

Common

Ocular disorders: ocular irritation

Uncommon

Ocular disorders: itching in the eye, redness of the eye, blurred vision, corneal disorder

Rare

Immune system disorders: hypersensitivity

Ocular disorders: small marks on the surface of the eye (punctate keratitis), inflammation and ulceration of the cornea (ulcerative keratitis), thinning of the cornea, defect in the outer layer of the cornea, inflammation of the cornea.

Respiratory, thoracic, and mediastinal disorders: dyspnea (difficulty breathing), worsening of asthma.

Skin and subcutaneous tissue disorders: redness (erythema), itching

Frequency Not Known

Infections and infestations: rhinitis

Ocular disorders: redness of the conjunctiva (conjunctival hyperemia), allergic conjunctivitis, redness of the eyelids (eyelid erythema), ocular allergy, inflammation of the eyelids, itching of the eyelids

Respiratory, thoracic, and mediastinal disorders: cough

Skin and subcutaneous tissue disorders: urticaria, rash, eczema.

Reporting Side Effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Diclofenac-Lepori Eye Drops, Single-Dose Container

Keep this medication out of the sight and reach of children.

No special storage conditions are required.

After opening the aluminum pouch, the product must be used within 60 days.

This medication does not contain preservatives. After opening and after use, the single-dose container must be discarded, even if it has only been partially used.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medications in the pharmacy's SIGRE collection point. If you have any questions, ask your pharmacist how to dispose of the packaging and any unused medications. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Diclofenac-Lepori Eye Drops, Single-Dose Container:

The active ingredient is diclofenac sodium. One milliliter of eye drops contains 1 mg of this active ingredient.

  • Each 0.3 ml container of eye drops in solution contains 0.3 mg of diclofenac sodium.
  • The other components are ricinoleic acid polyoxyethylene, L-lysine monohydrate, boric acid (E-284), sodium borate (borax) (E-285), sodium chloride, disodium edetate, water for injectable preparations.

Appearance of the Product and Package Contents

Diclofenac-Lepori 1 mg/ml Eye Drops, Solution, Single-Dose Container is presented in cartons containing 3 polyethylene and aluminum pouches, with two strips of 5 single-dose containers of low-density polyethylene each. Each container contains 0.3 ml of eye drops in solution.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

ANGELINI PHARMA ESPAÑA, S.L.

c/ Antonio Machado, 78-80

3rd floor, module A-Australia Building

08840 Viladecans, Barcelona (Spain)

Manufacturer

Laboratoire UNITHER

1 Rue De L’Arquerie

50200 Coutances – France

Date of the Last Revision of this Package Leaflet: August 2024

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
The active ingredient in DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is diclofenac. This information helps identify medicines with the same composition but different brand names.
How much does DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS cost in pharmacies?
The average pharmacy price for DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is around 7.52 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Angelini Pharma Espana S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DICLOFENAC-LEPORI 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (diclofenac) include DICLOABAK 1 mg/ml EYE DROPS SOLUTION, DICLOFENAC ABAMED 1 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, DICLOFENAC-LEPORI 1 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media